VIR BIOTECHNOLOGY INC's ticker is and the CUSIP is 92764N902. A total of 4 filers reported holding VIR BIOTECHNOLOGY INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $282,037 | -71.3% | 30,100 | -24.9% | 0.00% | – |
Q2 2023 | $983,653 | -13.6% | 40,100 | -18.0% | 0.00% | – |
Q1 2023 | $1,137,903 | -29.3% | 48,900 | -23.1% | 0.00% | -100.0% |
Q4 2022 | $1,609,716 | -7.2% | 63,600 | -29.3% | 0.00% | 0.0% |
Q3 2022 | $1,735,000 | -58.5% | 90,000 | -45.2% | 0.00% | -50.0% |
Q2 2022 | $4,182,000 | – | 164,200 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
GROUP ONE TRADING, L.P. | 50,500 | $1,175,135 | 0.00% |
SIMPLEX TRADING, LLC | 49,000 | $1,140 | 0.00% |
JPMORGAN CHASE & CO | 33,000 | $768,000 | 0.00% |
JANE STREET GROUP, LLC | 48,900 | $1,137,903 | 0.00% |
CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |